- Price
Supplier Type
- Manufacturer
- Reagent
- Trader
- contract manufacturer
- custom synthesis
Supplier Region
- Hyderabad(1)
- Gujarat(1)
- Ahmedabad(1)
- Mumbai(4)
- Andhra Pradesh(1)
Purity
- United States Pharmacopeia (USP) Reference Standard
- powder
- mixture of isomers, ethanol solution, ≥97% (GC)
- mixture of isomers, analytical standard
- Greater than 99%
- European Pharmacopoeia (EP) Reference Standard
- certified reference material, 10?mg/mL in heptane, ampule of 1?mL
- certified reference material, 10?mg/mL in heptane
- BCR?, certified reference material
- Avanti Polar Lipids (857511P), powder
- analytical standard
- AldrichCPR
- 99-100%
- >99.0%(T)
- >99.0%(GC)
- ≥99%, liquid
- ≥99% (GC), liquid
- ≥99% (GC)
- ≥99% (capillary GC), liquid
- ≥99% (capillary GC)
- ≥99%
- ≥99 atom % D, ≥99% (CP)
- 99 atom % 13C, 99% (CP)
- 99 atom % 13C, 97% (CP)
- 99 atom % 13C
- 98+
- ≥98.5% (GC), liquid
- ≥98.5% (GC)
- ≥98.5% (capillary GC), liquid
- >98.0%(T)
- >98.0%(GC)(T)
- >98.0%(GC)
- ≥98.0% (GC)
- ≥98%, liquid
- ≥98% (GC)
- ≥98% (capillary GC)
- 98% (capillary GC)
- 98%
- ≥98%
- 98 atom % D, 99% (CP)
- ≥98 atom % D, ≥99% (CP)
- ≥98 atom % D, ≥98% (CP)
- >97.0%(GC)
- ≥97.0% (TLC), oil
- ≥97.0% (T)
- ≥97%, liquid
- ≥97% (capillary GC)
- ≥97%
- >96.0%(HPLC)
- >96.0%(GC)
- ≥96%, mixture of isomers
- >95.0%(GC)
- ≥95% (GC)
- ≥95%
- 90 % Above
- ≥85%
- >80.0%(GC)
- 75%+
- >60.0%(GC)
- 10±0.5?μg/mL in isooctane, analytical standard
- 10?μg/mL in isooctane, analytical standard
- ~99%
- ~100?μg/mL in ethanol, ≥90% (HPLC)
- (Stearic acid 50 vegetable grade), EMPROVE? ESSENTIAL, Ph. Eur., BP, JP, NF
Package
- 10μg
- 50μg
- 1mg
- 5mg
- 10mg
- 20mg
- 25mg
- 50MG
- 100mg
- 110mg
- 125mg
- 200mg
- 250mg
- 500mg
- 0.5mL
- 1ML
- 1g
- 1gm
- 2mL
- 5g
- 5ML
- 5gm
- 10g
- 25g
- 25gm
- 25ML
- 100gm
- 100g
- 250g
- 500ml
- 500gm
- 500g
- 1kg
- 5lt
- 5kg
- 10kg
- 20kg
- 25kg
- 100kg
- 1MT
- 1kit
- 18%
- 25Gms
- 100Gms
- 89072101-DNA-5UG
2,2’,4,4’,6,6’-HEXACHLOROBIPHENYL 33979-03-2
Sodium octanoate-1-13c 95% 201612-61-5
Sodium octanoate-1-13C 201612-61-5







